Clinical Trials Logo

Filter by:
NCT ID: NCT01836393 Completed - Knee Osteoarthritis Clinical Trials

Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels

OA knee Plai
Start date: January 2013
Phase: Phase 3
Study type: Interventional

To determine whether plai cream is effective in treating mild to moderate degrees of osteoarthritis of the knee in the elderly patient compared with placebo cream.

NCT ID: NCT01833585 Completed - Atherosclerosis Clinical Trials

Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells

Start date: April 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of G-CSF-mobilized autologous peripheral blood mononuclear cell injection to ischemic limbs of patients with critical limb ischemia.

NCT ID: NCT01831206 Completed - Bacterial Keratitis Clinical Trials

Collagen Cross-linking in Infectious Keratitis Trial

Start date: March 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.

NCT ID: NCT01828099 Completed - Clinical trials for Non-Small Cell Lung Cancer

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

Start date: July 9, 2013
Phase: Phase 3
Study type: Interventional

The primary purpose of the study was to compare the antitumor activity of LDK378 versus reference chemotherapy. Patients in the chemotherapy arm were given the option to switch to LDK378 after confirmed progressive disease (PD), while also had the choice to continue with pemetrexed treatment.

NCT ID: NCT01828073 Completed - HIV Infections Clinical Trials

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

Start date: May 19, 2011
Phase:
Study type: Observational

The purpose of this study was to determine the washout pharmacokinetics (PK) and safety of in utero/intrapartum exposure to maternal raltegravir (RAL) in infants born to pregnant women with HIV infection who received RAL 400 mg twice daily. The study also provided data for the development of an infant RAL starting dosing regimen for IMPAACT P1110 (NCT01780831).

NCT ID: NCT01827176 Completed - Clinical trials for Acute Recurrent Sinusitis

Clinical Characteristic of Recurrent Acute Rhinosinusitis in Children

Start date: March 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine the clinical characteristic of recurrent acute rhinosinusitis in children.

NCT ID: NCT01819038 Completed - Acute Renal Failure Clinical Trials

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

EarlyRRT
Start date: January 2013
Phase: N/A
Study type: Interventional

This research project is a prospective study to compare mortality between early renal replacement therapy (RRT) and late renal replacement therapy by using plasma neutrophil gelatinase associated lipocalin (pNGAL) as a tool in decision- making.

NCT ID: NCT01818596 Completed - HIV Infections Clinical Trials

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Start date: March 27, 2013
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) tablet on renal parameters at Week 24 in treatment-naive and treatment-experienced HIV-positive, adults with mild to moderate renal impairment.

NCT ID: NCT01816243 Completed - Chronic Pain Clinical Trials

An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Thai Participants With Chronic Non-Malignant Pain

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Transdermal Therapeutic System (TTS)-fentanyl patch (transdermal patch containing a drug that is put on the skin so the drug will enter the body through the skin) in Thai participants with chronic (lasting a long time) non-malignant (non-cancerous) pain.

NCT ID: NCT01815736 Completed - HIV Infections Clinical Trials

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Start date: March 27, 2013
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the non-inferiority of switching to a tenofovir alafenamide (TAF)-containing fixed dose combination (FDC) relative to maintaining tenofovir disoproxil fumarate (TDF)-containing combination regimens in virologically suppressed HIV-infected participants as determined by having HIV-1 RNA < 50 copies/mL at Week 48.